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Background: Extravascular lung water (EVLW), as measured by the thermodilution method, reflects the extent
of pulmonary edema. Currently, there are no clinically effective treatments for preventing increases in pulmonary
vascular permeability, a hallmark of lung pathophysiology, in patients with acute lung injury/acute respiratory
distress syndrome (ALI/ARDS). In this study, we examined the contributions of hemodynamic and osmolarity
factors, for which appropriate interventions are expected in critical care, to EVLW in patients with ALI/ARDS.
Methods: We performed a subgroup analysis of a multicenter observational study of patients with acute
pulmonary edema. Overall, 207 patients with ALI/ARDS were enrolled in the study. Multivariate regression analysis
was used to evaluate the associations of hemodynamic and serum osmolarity parameters with the EVLW index
(EVLWI; calculated as EVLW/Ideal body weight). We analyzed factors measured on the day of enrollment (day 0),
and on days 1 and 2 after enrollment.
Results: Multivariate regression analysis showed that global end-diastolic volume index (GEDVI) was significantly
associated with EVLWI measured on days 0, 1, and 2 (P = 0.002, P < 0.001, and P = 0.003, respectively), whereas other
factors were not significantly associated with EVLWI measured on all 3 days.
Conclusions: Among several hemodynamic and serum osmolarity factors that could be targets for appropriate
intervention, GEDVI appears to be a key contributor to EVLWI in patients with ALI/ARDS.
Trial registration: University Hospital Medical Information Network (UMIN) Clinical Trials Registry UMIN000003627.
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Pulmonary edema is classified into cardiogenic and non-
cardiogenic types. Cardiogenic pulmonary edema is caused
by hydrostatic factors (e.g., volume overload and/or
pulmonary hypertension caused by inadequate cardiac
function), whereas non-cardiogenic pulmonary edema
is caused by vascular permeability, which is also known
as permeability pulmonary edema [1]. Both forms of
pulmonary edema are associated with increased extra-
vascular lung water. Extravascular lung water (EVLW)
can be measured by the transpulmonary thermodilution
technique and is strongly correlated with actual lung
weight at autopsy and at donor surgery, which reflects
pulmonary edema in humans [2-4].
Acute lung injury/acute respiratory distress syndrome
(ALI/ARDS) is one of the most common types of perme-
ability pulmonary edema. Among patients with ALI/
ARDS, an increase in EVLW is associated with increased
risk of mortality [5]. In most types of cardiogenic pulmon-
ary edema, increases in EVLW are caused by volume over-
load by fluid infusion in the presence of inadequate cardiac
function. By comparison, the risk factors for permeability
pulmonary edema in ALI/ARDS, for which appropriate
interventions are expected in critical care, are still un-
known. In terms of the pathophysiology of ALI/ARDS,
the most important treatment target is to inhibit the
increase in pulmonary permeability; currently, however,
there are no effective agents and/or ventilator strategies
for use in clinical settings. Our preliminary study showed
that hemodynamic and osmolarity parameters were risk
factors for hydrostatic and permeability pulmonary edema
[6]. This is important because hemodynamic and osmo-
larity factors could be controlled by the physician. In
this context, the aim of this study was to identify hemo-
dynamic and/or osmolarity risk factors for an increase
of extravascular lung water index (EVLWI) that could




Between March 2009 and August 2011, we conducted
a multicenter observational study to assess the clinical
diagnosis of cardiogenic and non-cardiogenic pulmon-
ary edema, which were assessed using the transpul-
monary thermodilution technique [7]. The protocol of
this subgroup analysis was approved by the institu-
tional review boards of all participating institutions,
and written informed consent was provided by each
patient’s next of kin. The investigation was registered
with the University Hospital Medical Information Net-
work (UMIN) Clinical Trials Registry (UMIN-CTR ID:
UMIN000003627).Patients
The inclusion and exclusion criteria were the same as
those in our previous study [7]. Patients aged >15 years
old were eligible if they required mechanical ventilation,
had a PaO2/FiO2 ratio of ≤300 mmHg, had bilateral
infiltration on chest X-ray images, and were monitored
by transpulmonary thermodilution. Exclusion criteria
included the following: >5 days since the onset of respira-
tory failure, chronic lung disease, history of a pulmonary
operation, pulmonary embolism, severe peripheral artery
disease, cardiac index (CI) of <1.5 L/min · m2 with cardio-
genic shock, lung contusion or burns, or the attending
physician considered the patient as inappropriate for
this study. Data from 207 patients with ALI/ARDS that
was diagnosed by three or more experts in intensive
care, respiratory, and cardiology, with appropriate clinical
findings (e.g., medical history, physiological findings, radio-
logical data, laboratory data, and echocardiography), were
analyzed in this study.
Measurements
Transpulmonary thermodilution was performed using the
PiCCO® monitor (Pulsion Medical Systems SE, Munich,
Germany) in all institutions. A 4- or 5-Fr femoral arterial
thermistor-tipped catheter (PC2014L16 or PV2015L20;
Pulsion Medical Systems SE) was inserted into the patient
and was connected to the PiCCO® plus or PiCCO® 2 moni-
tor. The PiCCO® monitor uses the single-thermal indicator
technique to calculate volumetric parameters. A bolus of
15 mL of cold saline is injected through a central venous
catheter, and thermal variation is detected by the thermis-
tor at the tip of the arterial catheter. Cardiac output is
calculated using the Stewart-Hamilton method. The
mean transit time and the exponential downslope time
of the transpulmonary thermodilution curve are also
calculated by this system. Each value provided by the
PiCCO® monitor was calculated as the mean of three
bolus injections of normal saline [8]. Each value was
indexed according to the patient’s height and ideal body
weight using the following formula: Body weight (kg) =
50 + 0.91 (Height (cm) – 152.4) for males and body
weight = 45.5 + 0.91 (Height (cm) – 152.5) for females,
as previously reported [9].
The transpulmonary thermodilution technique calcu-
lates the CI, global end-diastolic volume index (GEDVI)
(corresponding to global diastolic cardiac volume in rela-
tion to preload), and EVLWI (a quantitative assessment of
pulmonary edema [2-4] calculated as Extravascular lung
water/Ideal body weight). Analysis of the arterial pulse
contour by the PiCCO® monitor also provides other pa-
rameters, including continuous cardiac output and the
stroke volume variation (SVV), which is the percentage
in respiratory-induced stroke volume variation in relation
to preload.
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identify which of the following hemodynamic and osmo-
larity parameters were associated with EVLWI: GEDVI,
SVV, and central venous pressure (CVP) as preload
parameters, systemic vascular resistance index (SVRI)
as afterload parameter, CI as hemodynamic parameter,
and albumin (ALB) and serum osmolarity (OSM) as
serum osmolarity parameters. OSM was calculated using
the formula: OSM= 2(Na + K) + BS/18 + BUN/2.8, where
Na = sodium concentration (mmol/L), K = potassium con-
centration (mmol/L), BS = blood sugar concentration
(mg/dL), and BUN = blood urea nitrogen concentration
(mg/dL). These data were obtained on the day of enroll-
ment (day 0) and on days 1 and 2 after enrollment. OSM
was only determined on day 0.Statistical analysis
Statistical analyses were performed using SPSS software
version 16.0 (IBM, Armonk, NY, USA). Univariate analyses
were performed using Student’s t test. Multivariate regres-
sion analyses were performed with a stepwise procedure to
identify the statistically significant factors associated with
the dependent variable, EVLWI. The independent variables
were age, sex (‘male’ was treated as a variable), GEDVI,
SVV, CVP, SVRI, CI, ALB, and OSM. Correlation analysis
was performed using Pearson’s correlation test. The ana-
lyses were performed for each day of measurement. All
statistical analyses were considered significant at P < 0.05.Results
The characteristics and parameters measured in the 207
patients are summarized in Table 1. The mean age was
66.7 years old. There were 134 males and 73 females,
and 61.8% had sepsis. The mean APACHE II score,
SOFA score, PaO2/FiO2 ratio, and lung injury score [10]
were 23.4, 10.7, 150.5 mmHg, and 2.3, respectively. The
28-day mortality rate was 40.6%. The comparison between
survivor and non-survivor, age, APACHE II score, SOFA
score, CVP on day 1, SVV on day 2, and CVP on day 2
were significantly different.
Table 2 shows the results of the multivariate regression
analysis performed using the stepwise procedure. GEDVI
and CI were significantly associated with EVLWI on day 0
(P = 0.002 and P = 0.023, respectively). GEDVI and sex were
significantly associated with EVLWI on day 1 (P < 0.001
and P = 0.015, respectively). Sex, GEDVI, and SVRI were
significantly associated with EVLWI on day 2 (P = 0.002,
P = 0.003, and P = 0.049, respectively).
Figure 1 shows the results of Pearson’s correlation test
between GEDVI and EVLWI. Pearson’s correlation coef-
ficients in day 0, 1, and 2 were 0.283, 0.343, and 0.264,
respectively (P < 0.001 in each day).Discussion
The results of multivariate regression analysis suggested
that in patients with ALI/ARDS, EVLWI was strongly
associated with GEDVI measured for 3 days after enroll-
ment in this study. The management of hemodynamic
status by diuresis and limited fluid infusion in patients
with cardiogenic pulmonary edema is already well estab-
lished [11]. By contrast, the management of permeability
pulmonary edema in ALI/ARDS is still not well defined.
Because the severity of cardiogenic pulmonary edema is
related to the patient’s hemodynamic status, then logic-
ally, the hemodynamic monitoring technique should
follow this pathophysiology. However, in patients with
ALI/ARDS, permeability pulmonary edema is not directly
proportional to hemodynamic parameters [7]. In the pre-
sent study, EVLWI was used to quantify pulmonary
edema and was strongly associated with GEDVI measured
on all 3 days, suggesting that appropriate control of
the circulating blood volume is an important factor in
the management of not only cardiogenic edema but
also permeability pulmonary edema. Consequently,
GEDVI could also be a target for the management of
ALI/ARDS.
Options for fluid management in patients with ALI/
ARDS have already been assessed in a randomized con-
trolled trial, where a conservative fluid strategy to control
blood volume, by avoiding excessive water balance, im-
proved the oxygenation index, lung injury score, and
ventilator-free days but did not affect mortality [12].
Another study showed that mortality was increased in
patients who did not receive adequate fluid manage-
ment (an initial fluid bolus and avoidance of a positive
water balance for 1 week) [13]. Although EVLWI and
GEDVI were not evaluated in those studies, adequate
blood volume management may improve lung function.
GEDVI is an index of preload regulation. Although the
management of blood volume improves lung function
[12,13], target GEDVI levels have not been defined. In
fact, the target GEDVI should be conservative, with
limited fluid infusion, to avoid worsening of EVLWI.
However, if fluid management is too conservative, it
may result in inadequate blood volume that can cause
organ ischemia. Therefore, an appropriate target of GEDVI
should be established [14]. Moreover, recent studies have
shown that pulmonary permeability can be monitored
and quantified using the transpulmonary thermodilution
technique [7,15-17]. The target GEDVI level may need
to be adjusted according to the severity of pulmonary
permeability by evaluating the cutoff value for increases
in EVLWI, although this needs to be investigated in future
studies. However, in tradition, other preload parameters
(CVP, SVV, etc.) did not show the target value; therefore,
it is unclear whether the target GEDVI could be shown
or not.
Table 1 Patient characteristics
Variable All cases Survivor Non-survivor P value
n 207 123 84
Age (years) 66.7 ± 16.8 63.9 ± 17.6 70.7 ± 14.9 0.004
Male 134 (64.7%) 77 (62.6%) 57 (67.9%) 0.437
Sepsis, yes 128 (61.8%) 70 (56.9%) 58 (69.0%) 0.078
APACHE II score 23.4 ± 8.1 21.9 ± 7.8 25.6 ± 8.1 0.001
SOFA score 10.7 ± 3.6 10.0 ± 3.2 11.8 ± 3.7 <0.001
PaO2/FiO2 ratio (mmHg) 150.5 ± 70.9 155.8 ± 70.2 142.8 ± 71.6 0.195
Lung injury score 2.3 ± 0.6 2.3 ± 0.6 2.3 ± 0.6 0.702
28-day mortality rate 84 (40.6%) 0 (0%) 84 (100%) -
Day 0
EVLWI (mL/kg) 18.5 ± 6.8 18.5 ± 6.9 18.5 ± 6.7 0.981
GEDVI (mL/m2) 816.8 ± 205.7 823.0 ± 211.8 807.5 ± 197.2 0.595
SVV (%) 15.7 ± 6.9 15.4 ± 7.3 16.1 ± 6.4 0.472
CVP (mmHg) 10.2 ± 5.3 9.8 ± 4.9 10.7 ± 5.8 0.221
CI (L/min · m2) 3.5 ± 1.3 3.6 ± 1.2 3.3 ± 1.3 0.171
SVRI (dyn · s · cm−5 · m2) 1,805 ± 866 1,716 ± 707 1,932 ± 1,043 0.083
ALB (g/dL) 2.6 ± 0.7 2.6 ± 0.7 2.6 ± 0.7 0.509
OSM (mOsm/L) 304.7 ± 16.7 303.5 ± 15.6 306.4 ± 18.1 0.227
PEEP (cmH2O) 8.7 ± 4.7 8.8 ± 4.7 8.5 ± 4.8 0.720
Day 1
EVLWI (mL/kg) 17.7 ± 7.4 17.3 ± 7.2 18.4 ± 7.8 0.280
GEDVI (mL/m2) 821.4 ± 222.5 828.8 ± 222.3 810.1 ± 223.7 0.561
SVV (%) 14.2 ± 7.6 14.0 ± 8.7 14.6 ± 5.7 0.581
CVP (mmHg) 10.6 ± 4.8 9.9 ± 4.4 11.7 ± 5.2 0.007
CI (L/min · m2) 3.5 ± 1.2 3.6 ± 1.1 3.3 ± 1.3 0.119
SVRI (dyn · s · cm−5 · m2) 1,880 ± 852 1,865 ± 873 1,902 ± 824 0.767
ALB (g/dL) 2.5 ± 0.6 2.5 ± 0.6 2.4 ± 0.6 0.304
PEEP (cmH2O) 8.9 ± 5.2 9.0 ± 5.1 8.9 ± 5.5 0.934
Day 2
EVLWI (mL/kg) 16.4 ± 7.4 15.7 ± 6.4 17.7 ± 8.8 0.077
GEDVI (mL/m2) 858.3 ± 238.2 844.7 ± 237.2 880.2 ± 239.7 0.315
SVV (%) 12.4 ± 5.9 10.9 ± 5.5 14.7 ± 5.8 <0.001
CVP (mmHg) 10.4 ± 5.0 9.6 ± 4.3 11.7 ± 5.7 0.004
CI (L/min · m2) 3.7 ± 1.3 3.7 ± 1.3 3.7 ± 1.3 0.920
SVRI (dyn · s · cm−5 · m2) 1,791 ± 733 1,791 ± 733 1,791 ± 733 0.977
ALB (g/dL) 2.5 ± 0.6 2.5 ± 0.6 2.5 ± 0.6 0.880
PEEP (cmH2O) 8.5 ± 5.0 8.5 ± 4.9 8.5 ± 5.3 0.947
Values are means ± standard deviation or n (%). P value: survivor vs. non-survivor. The italicized values are statistically significant. APACHE acute physiology and
chronic health evaluation, SOFA sequential organ failure assessment, EVLWI extravascular lung water index, GEDVI global end-diastolic volume index, SVV stroke
volume variation, CVP central venous pressure, CI cardiac index, SVRI systemic vascular resistance index, ALB serum albumin, OSM calculated serum osmotic pressure
(OSM= 2(Na + K) + BS / 18 + BUN / 2.8, where Na = sodium concentration (mmol/L), K = potassium concentration (mmol/L), BS = blood sugar concentration (mg/dL),
and BUN= blood urea nitrogen concentration (mg/dL)), PEEP positive end-expiratory pressure.
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as decreased ALB and increased OSM, were positively
associated with EVLWI [6], which was not confirmed in
this study. In patients with ALI/ARDS, it was reportedthat albumin infusion and diuresis did not improve mor-
tality, but did improve oxygenation [18,19]. These pre-
liminary results suggest that serum osmolarity factors
may decrease EVLWI, although this was not statistically
Table 2 Results of multivariate regression analysis with EVLWI as the dependent variable
Variable P value Regression coefficient (95% confidence interval) Standard regression coefficient
Day 0
GEDVI 0.002 0.009 (0.004, 0.015) 0.272
CI 0.023 −1.045 (−1.941, −0.148) −0.195
R2 = 0.076 0.003
Day 1
GEDVI <0.001 0.011 (0.006, 0.017) 0.330
Sex (male) 0.015 −3.045 (−5.500, −0.590) −0.188
R2 = 0.135 <0.001
Day 2
Sex (male) 0.002 −4.161 (−6.764, −1.557) −0.256
GEDVI 0.003 0.008 (0.003, 0.014) 0.251
SVRI 0.049 0.002 (0.000, 0.003) 0.158
Age 0.051 0.074 (0.000, 0.148) 0.162
R2 = 0.181 <0.001
Regression analyses were performed using the stepwise procedure. EVLWI extravascular lung water index, GEDVI global end-diastolic volume index, CI cardiac
index, SVRI systemic vascular resistance index.
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control blood volume may be an important factor in
patients with severely increased pulmonary permeability.
Current data suggest that fluid resuscitation of albumin
for severe sepsis and septic shock is recommended over
hydroxyethyl starch [20], which can be used in the early
phase of ALI/ARDS resuscitation without worsening





























r = 0.283, P<0.001
Day 2
r = 0.264, P<0.001
Figure 1 Correlation between extravascular lung water index (EVLWI)
Pearson’s correlation coefficients in days 0, 1, and 2 were 0.283, 0.343, andcantly associated with EVLWI in the present study, the
type of fluid used for resuscitation should be assessed in
future studies.
In the present study, most of the significant parame-
ters were from hemodynamics (GEDVI, CI, and SVRI).
However, sex was other significant parameter on days 2
and 3. These results showed that females had advantage












r = 0.343, P<0.001
and global end-diastolic volume index (GEDVI) in each day.
0.264, respectively (P < 0.001 in each day).
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there is a possibility that gender could affect EVLWI,
because of strong relationship between EVLWI and
GEDVI in our data.
Our data showed a 40.6% 28-day mortality rate, and
the average APACHE II score was 23.4. The average age
of the non-survivor cases was significantly older (survivor
vs. non-survivor 63.9 vs. 70.7, P = 0.004), and the non-
survivor cases had tendency of high GEDVI and EVLWI
on later days. It might be a result of fluid management
protocol, which was not defined in this study. These
results also indicated that there might be better fluid
management.
Our study has several limitations. First, it was con-
ducted as a secondary subgroup study, which means that
the results should be confirmed in a prospective study.
Second, the severity of pulmonary permeability was not
considered, and the classification of pulmonary perme-
ability may alter the results.
Multivariate analysis showed that GEDVI was the most
predictor for an increase in EVLWI. These results are con-
sistent with those of earlier fluid management studies
in patients with ALI/ARDS [12,13]. To aid the clinical
management of patients with ALI/ARDS, we suggest that
EVLWI and GEDVI should be measured to examine their
clinical relevance as potential therapeutic targets. This
possibility should be confirmed in a future study.
Conclusions
EVLWI as a quantitative marker of pulmonary edema is
strongly associated with GEDVI in patients with ALI/
ARDS. Therefore, GEDVI may be a therapeutic target to
help control extravascular lung water. Prospective stud-
ies are needed to examine the effects of targeting GEDVI
for improving EVLWI and clinical outcomes in patients
with ALI/ARDS.
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